Modern drugs should be characterized by low toxicity and high efficiency [4] . Determination of the acute toxicity of substances is the first stage when considering toxicological characteristics; its aim is to obtain information concerning the substance danger to health in terms of the short-term action. These data can be taken as a basis for toxicity class determination. Taking into account the possibility of random situations that cause accidents, suicide and criminal poisonings it is expedient to determine the acute toxicity for the oral route of administration [1] . To study the toxicity of substances the pharmacological model, which makes possible to study the effects on the experimental animals, is created.
The aim of this study was to determine the acute toxicity of new pharmacologically active derivatives of benzilic acid.
Materials and Methods
The study objects included 17 new derivatives of benzilic acid synthesized at the Department of Organic Chemistry of the National University of Pharmacy. Determination of the acute toxicity was conducted according to the guidelines "Preclinical studies of drugs" edited by O.Stefanov in outbred mice weighing 20-26 g. They were kept in the vivarium of the Central Research Laboratory of the National University of Pharmacy in standard conditions on a normal diet with a free access to food and water [1] . Animals were divided into 68 groups of 5 mice each. Each group of animals received the aqueous solution of the substance under study once orally by gavage in the doses of 100, 250, 750, 1000 mg/kg [2] . The total duration of follow-up of the animals after administration of the test substance was 14 days. The following parameters were taken into account: appearance, behaviour of animals, condition of hair, visible mucous membranes, attitude to food, rhythm, respiratory rate, time of occurrence and nature of intoxication, its severity, course, and time of the animals' death or recovery [5] . The experiment was carried out in strict compliance with the requirements of the European Convention "On protection of vertebrate animals used for experimental and other scientific purposes" (Strasbourg, 1986) [3] .
Results and Discussion
The results obtained within 14 days of observation of the laboratory animals received the test compounds in the dose of 1000 mg/kg are given in Tab. 1. In the early days of the experiment the animals remained active, agile, had normal motor coordination, standard response to external stimuli, normal appearance, and that was similar to the group of control animals. On the third and eighth days of the study one animal died from each group receiving the aqueous solutions of products of cyclization of benzilic acid amides containing the fragment of 2-oxo-3,3-diphenyl-2,3-dihydro-1H-thieno [3, 4-b] pyrrole-6-carboxylic acid -KMS-72 and KMS-69, respectively. On the eighth day of the experiment one animal also died from each group receiving the dose of 3-indolilamid of benzilic acid (KMS-283) and thienolactams with six-membered (KMS-303) and seven-membered (KMS-258) cycles. Animals receiving the substance KMS-72 (1 mouse), KMS-282 (2 mice) had wounds on their back, and mice from groups receiving KMS-229, KMS-230, KMS-282 KMS-303 had problems with their eyes. On the background of all experimental animals the mouse receiving the substance KMS-282 was very weak and ISSN 2415-8844 (Online) ISSN 1562-7241 (Print) died the next day, and the animal from another group of thienolactam studied with seven-membered cycle (KMS-229) also died. On the eleventh day of the study we lost another 3 animals: one mouse from KMS-282 group and two mice receiving the substance KMS-229. Introduction of this substance resulted in death of 3 animals due to its toxic effects; there were no visible changes in behaviour or appearance of the experimental animals. In the group of animals receiving dimethyl-substituted 3-indolilamid (KMS-282) two animals died: one mouse, as mentioned above, had wounds on its back, another mouse experienced disorientation in space and the motor activity impairment on the background of eye lesions.
It should be also noted that when introducing substances KMS-69 and KMS-303 the inhibition of the visual analyzer response was observed in the experimental animals.
When studying toxicity of the test compounds administered to laboratory animals in the doses of 100, 250, 750 mg/kg no animals died, their appearance and behaviour did not change within the entire observation period (Tab. 2).
Thus, within 14 days of observation in groups of animals received the new derivatives of benzilic acid under the codes KMS-10, KMS-19, KMS-49, KMS-68, MS-70, KMS-71, KMS-73, KMS-228, KMS-230, KMS-284
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